111 related articles for article (PubMed ID: 8960273)
1. Esters of cephalosporins. Part II. Differences in the properties of various forms of the 1-acetoxyethyl ester of cefuroxime.
Oszczapowicz I; Małafiej E; Szelachowska M; Horoszewicz-Małafiej A; Kuklewicz C; Sierańska E; Denys A; Niedworok J
Acta Pol Pharm; 1995; 52(5):397-401. PubMed ID: 8960273
[TBL] [Abstract][Full Text] [Related]
2. Esters of cephalosporins. Part III. Separation and properties of the R and S isomers of the 1-acetoxyethyl ester of cefuroxime.
Oszczapowicz I; Małafiej E; Horoszewicz-Małafiej A; Szelachowska M; Kuklewicz C; Sierańska E
Acta Pol Pharm; 1995; 52(6):471-6. PubMed ID: 8960265
[TBL] [Abstract][Full Text] [Related]
3. Esters of cephalosporins. Part VI. Properties of the beta-form of 1-acetoxyethyl ester of cefuroxime.
Oszczapowicz I; Tejchman B; Zimniak A; Oszczapowicz J
Acta Pol Pharm; 1998; 55(3):197-204. PubMed ID: 9735700
[TBL] [Abstract][Full Text] [Related]
4. Esters of cephalosporins. Part I. Permeability of cefuroxime liberated from its 1-acetoxyethyl ester through biological membranes; influence of the form and size of the ester particles.
Sasinowska-Motyl M; Wiśniewska I; Gumułka W; Oszczapowicz I; Szelachowska M; Interewicz B
Acta Pol Pharm; 1995; 52(5):391-5. PubMed ID: 8960272
[TBL] [Abstract][Full Text] [Related]
5. Model simulation of a single oral dose of cefuroxime axetil and the related in-vitro kill kinetics against four bacterial species.
Silley P; Monsey D; Harris AM
J Antimicrob Chemother; 1990 Jan; 25(1):83-90. PubMed ID: 2180892
[TBL] [Abstract][Full Text] [Related]
6. Esters of cephalosporins. Part IV. Hydrolysis of 1-acetoxyethyl ester of cefuroxime in vitro and in vivo.
Tejchman B; Jaromińska M; Horodecka M; Oszczapowicz I
Acta Pol Pharm; 1995; 52(6):477-82. PubMed ID: 8960266
[TBL] [Abstract][Full Text] [Related]
7. Stereoselective absorption and hydrolysis of cefuroxime axetil diastereomers using the Caco-2 cell monolayer model.
Barrett MA; Lawrence MJ; Hutt AJ; Lansley AB
Eur J Drug Metab Pharmacokinet; 1997; 22(4):409-13. PubMed ID: 9512942
[TBL] [Abstract][Full Text] [Related]
8. [Cefuroxime axetil].
Matsumoto F; Oizumi K
Jpn J Antibiot; 1988 Sep; 41(9):1181-93. PubMed ID: 3071614
[No Abstract] [Full Text] [Related]
9. In vitro bactericidal action of cefoperazone, cefoxitin, cefuroxime, cefazolin and cephaloridine.
Piantieri G; Cafarelli A; Magliulo E
G Batteriol Virol Immunol; 1981; 74(1-6):15-25. PubMed ID: 6458524
[No Abstract] [Full Text] [Related]
10. [Pharmacokinetics of cefixime in volunteers and a literature comparison with the new ester prodrug cephalosporins].
Kees F; Naber KG
Infection; 1990; 18 Suppl 3():S150-4. PubMed ID: 2079377
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo evaluations of a new broad-spectrum oral cephalosporin, BMY-28232, and its prodrug esters.
Tomatsu K; Masuyoshi S; Hirano M; Kawaguchi H; Oki T; Fung-Tomc J; Desiderio JV; Kessler RE
Antimicrob Agents Chemother; 1989 Apr; 33(4):489-97. PubMed ID: 2786371
[TBL] [Abstract][Full Text] [Related]
12. In vitro bactericidal action of cephalosporins in different concentrations of serum.
Magliulo E; Ceccarelli G; Bianchi PP; Piantieri G; Cafarelli A
G Batteriol Virol Immunol; 1981; 74(1-6):39-47. PubMed ID: 6458527
[No Abstract] [Full Text] [Related]
13. Cefuroxime axetil.
Med Lett Drugs Ther; 1988 Jun; 30(767):57-9. PubMed ID: 3367854
[No Abstract] [Full Text] [Related]
14. Kill kinetics of the cephalosporin antibiotics cephalexin and cefuroxime against bacteria of veterinary importance.
Silley P; Brewster G
Vet Rec; 1988 Sep; 123(13):343-5. PubMed ID: 3057718
[TBL] [Abstract][Full Text] [Related]
15. [Cefuroxime axetil (Zinnat)--laboratory and clinical study].
Vyhnánek F; Hejzlar M; Procházka M; Pellar T; St'astná L; Silarová J; Kittnar E; Vedral T
Rozhl Chir; 1990 Oct; 69(10):668-73. PubMed ID: 2263996
[TBL] [Abstract][Full Text] [Related]
16. [Oral cephalosporins. Role of cefuroxime-axetil].
Bergogne-Berezin E
Therapie; 1988; 43 Suppl 4():343-9. PubMed ID: 3065977
[No Abstract] [Full Text] [Related]
17. Pharmacokinetics and pharmacodynamics of two oral forms of cefuroxime axetil.
Garraffo R; Drugeon HB; Chiche D
Fundam Clin Pharmacol; 1997; 11(1):90-5. PubMed ID: 9182082
[TBL] [Abstract][Full Text] [Related]
18. Effects of the variations in inoculum on the cephalosporins' in vitro antibacterial activity.
Cafarelli A; Magliulo E; Piantieri G
G Batteriol Virol Immunol; 1981; 74(1-6):26-38. PubMed ID: 6458525
[No Abstract] [Full Text] [Related]
19. Bioavailability of cefuroxime axetil: comparison of standard and abbreviated methods.
Lang CC; Moreland TA; Davey PG
J Antimicrob Chemother; 1990 Apr; 25(4):645-50. PubMed ID: 2351625
[TBL] [Abstract][Full Text] [Related]
20. Penetration of oral cefuroxime axetil into the human aqueous humor.
Ghia M; Lotti R; Traverso C; Mattioli F; Martelli A
Ophthalmologica; 1997; 211(4):229-31. PubMed ID: 9216013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
